HYSBYSIAD O GONTRACT - CYFNODOLYN SWYDDOGOL
|
Adran I: Awdurdod Contractio
|
I.1)
|
Enw, Cyfeiriad a Phwynt(iau) Cyswllt
|
|
Cell Therapy Catapult |
12th Floor, Guy's Tower, Great Maze Pond |
London |
SE1 9RT |
UK |
Jodie Hill |
|
ojeu@ct.catapult.org.uk |
|
http://catapult.org.uk/celltherapy
|
|
|
|
|
|
|
|
|
|
I.2)
|
Math o Awdurdod contractio a'i Brif Weithgaredd neu Weithgareddau
|
Private Company Limited by Guarantee |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cell Therapies |
|
|
|
Na
|
Adran II: Amcan y Contract
|
II.1)
|
Disgrifiad
|
II.1.1)
|
Teitl a roddwyd i'r contract gan yr awdurdod contractio
Cell Therapy Catapult GMP Manufacturing Partners. |
II.1.2(a))
|
Math o gontract gwaith
|
II.1.2(b))
|
Math o gontract cyflenwadau
|
II.1.2(c))
|
Math o gontract gwasanaeth
8 |
II.1.2)
|
Prif safle neu leoliad y gwaith, man cyflawni neu berfformio
UK.
UK |
II.1.3)
|
Mae'r hysbysiad hwn yn ymwneud â
|
|
|
|
|
|
|
II.1.4)
|
Gwybodaeth am gytundeb fframwaith
(os yw'n berthnasol)
|
|
|
|
|
|
Nifer y cyfranogwyr a ragwelir yn y cytundeb fframwaith
30 |
|
Hyd y cytundeb fframwaith
4 |
|
Cyfiawnhad dros gytundeb fframwaith sy'n para am fwy na phedair blynedd
|
|
Amcangyfrif o gyfanswm gwerth pryniannau yn ystod cyfnod llawn y cytundeb fframwaith
25 000 000GBP |
|
Amlder a gwerth y contractau a gaiff eu dyfarnu
|
II.1.5)
|
Disgrifiad byr o'r contract neu'r pryniant/pryniannau
The Cell Therapy Catapult has recognised the need to engage with established Manufacturing Partners to leverage existing expertise across the Cell Therapy industry in its pursuit of the rapid development, delivery and commercialisation of cell therapies.
The Cell Therapy Catapult has internal activities for analytical, process development and manufacturing proving with its facilities on the 12th Floor of Guy's Hospital. It is desired to partner with centres of excellence for clinical manufacturing activities.
The Cell Therapy Catapult is engaged in numerous projects with an array of diverse products, and therefore wishes to engage in a framework agreement with several suppliers covering a wide range of skills and capabilities in order that these can be leveraged when required.
In order to fulfil its mission, the Cell Therapy Catapult needs to have access to sufficient manufacturing outsource providers to be able to confidently deliver on current and future projects across the entirety of the cell therapy industry. These projects could be internal Cell Therapy Catapult projects or those for which the Cell Therapy Catapult is acting on behalf of a client or partner. For this reason the Cell Therapy Catapult is looking to engage with outsource providers who may be able to offer one or more desired services in the following lots:
Lot 1: Immune cell therapy manufacture (including gene modified immune cell therapy).
Lot 2: Pluripotent derived cell therapy manufacture (iPS or hES).
Lot 3: MSC and other multi-potent cell therapy manufacture.
Lot 4: Other somatic cell therapy manufacture.
Lot 5: 3D culture based cell therapy manufacture.
To enable the manufacture in the specific lots the organisation should have experience, expertise and technology that includes the following activities where relevant to the particular lot:
— MHRA MIA(IMP) license for cell therapy applications (or equivalent local license outside of the UK);
— HTA license for donor material procurement testing (or equivalent local license outside of the UK);
— Hosting of GMP audits;
— Tech transfer support for incoming processes, including ability to absorb Catapult staff into the facility to aid tech transfer;
— Preparation of batch documentation;
— Manufacturing technologies and capability to enable processes may include but should not be limited to:
- Non-enclosed processing (using MBSCs within grade B background or isolators within grade C or grade D background);
- Enclosed processing (using closed systems in a grade C or grade D background);
- Adherent cell culture in T-flasks, cell factories and on microcarriers in bioreactors;
- Suspension culture of cells in static mode and in bioreactors;
- 3D culture of cells on surfaces;
- Cell separation;
- Cell activation;
- Differentiation;
- Volume reduction and washing of cells;
- Aseptic vial/bag filling;
- Product labelling;
- Cryopreservation;
— QC analytical testing of final products, in-process controls and raw materials;
— QA batch review;
— QP release of clinical material;
— Regular project meetings to report progress.
|
II.1.6)
|
Geirfa Gaffael Gyffredin (CPV)
|
|
|
|
33600000 |
|
|
|
|
|
II.1.7)
|
Contract wedi'i gwmpasu gan Gytundeb Caffael y Llywodraeth (GPA)
|
II.1.8)
|
Rhannu'n lotiau
Ie
|
|
|
|
|
|
|
II.1.9)
|
A gaiff cynigion amrywiadol eu derbyn?
Ie
|
II.2)
|
Maint neu Gwmpas y Contract
|
II.2.1)
|
Cyfanswm maint neu gwmpas
The total estimated value of call offs under the framework is GBP 25,000,000. |
|
25 000 000 GBP |
II.2.2)
|
Opsiynau
|
|
Amserlen dros dro ar gyfer defnyddio'r opsiynau hyn
|
|
Nifer yr adnewyddiadau posibl
|
|
Yn achos contractau cyflenwadau neu wasanaethau adnewyddadwy, amserlen amcangyfrifedig ar gyfer contractau dilynol
|
II.3)
|
Hyd y contract neu derfyn amser ar gyfer ei gwblhau
48 |
Adran III: Gwybodaeth Gyfreithiol, Economaidd, Ariannol a Thechnegol
|
III.1)
|
Amodau sy'n Ymwneud â'r Contract
|
III.1.1)
|
Adneuon a gwarantau sydd eu hangen
Tenderers may be requested to sign a Parent Company Guarantee, depending on the evaluation of Financial Information.
|
III.1.2)
|
Prif Delerau ariannu a thalu a/neu gyfeiriad at y darpariaethau perthnasol
|
III.1.3)
|
Y ffurf gyfreithiol i'w chymryd gan y grŵp o gyflenwyr, contractwyr neu ddarparwyr gwasanaeth y caiff y contract ei ddyfarnu iddo
|
III.1.4)
|
Amodau penodol eraill y mae perfformiad y contract yn ddarostyngedig iddynt
Any conditions will be detailed in the tender documents.
|
III.2)
|
Amodau ar gyfer Cymryd Rhan
|
III.2.1)
|
Sefyllfa bersonol gweithredwyr economaidd, gan gynnwys gofynion sy'n ymwneud â chofrestru ar gofrestrau proffesiynol neu fasnach
Please see the PQQ.
|
III.2.2)
|
Capasiti economaidd ac ariannol
Please see the PQQ.
Please see the PQQ.
|
III.2.3)
|
Capasiti technegol
Please see the PQQ.
Please see the PQQ.
|
III.2.4)
|
Contractau sydd wedi'u cadw
|
|
|
|
|
III.3)
|
Amodau sy'n Benodol i Gontractau Gwasanaeth
|
III.3.1)
|
A gaiff y gwaith o ddarparu'r gwasanaeth ei gadw ar gyfer proffesiwn penodol?
Na
|
III.3.2)
|
A fydd yn ofynnol i endidau cyfreithiol nodi enwau a chymwysterau proffesiynol y personél a fydd yn gyfrifol am ddarparu'r gwasanaeth?
Na
|
Adran IV: Gweithdrefn
|
IV.1)
|
Math o Weithdrefn
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cyfiawnhad dros ddewis gweithdrefn gyflym
|
IV.1.1)
|
A yw ymgeiswyr wedi'u dewis eisoes?
Na
|
IV.1.2)
|
Cyfyngiadau ar nifer y gweithredwyr a gaiff eu gwahodd i dendro neu gymryd rhan
2548 |
|
Meini prawf gwrthrychol ar gyfer dewis nifer cyfyngedig o ymgeiswyr
Please see the PQQ.
|
IV.1.3)
|
Lleihau nifer y gweithredwyr yn ystod y broses negodi neu'r deialog
|
|
|
IV.2)
|
Meini Prawf Dyfarnu
|
|
Na
|
|
|
|
Ie
|
|
Na
|
IV.2.2)
|
Defnyddir arwerthiant electronig
Na
|
IV.3 Gwybodaeth Weinyddol
|
IV.3.1)
|
Rhif cyfeirnod a roddwyd i'r hysbysiad gan yr awdurdod contractio
CON-0038
|
IV.3.2)
|
Cyhoeddiad(au) blaenorol sy'n ymwneud â'r un contract
|
|
|
|
Cyhoeddiadau blaenorol eraill
|
IV.3.3)
|
Amodau ar gyfer cael manylebau a dogfennau ychwanegol
23
- 06
- 2014
10:00
|
IV.3.4)
|
Terfyn amser ar gyfer derbyn tendrau neu geisiadau i gymryd rhan
23
- 06
- 2014
10:00 |
IV.3.5)
|
Dyddiad yr anfonwyd y gwahoddiadau i dendro neu'r gwahoddiadau i gymryd rhan at ymgeiswyr a ddewiswyd
|
IV.3.6)
|
Yr iaith neu'r ieithoedd y gellir ei/eu defnyddio i lunio tendrau neu geisiadau i gymryd rhan
|
IV.3.7)
|
Isafswm y cyfnod y mae'n rhaid i'r cynigiwr gadw'r tendr
|
IV.3.8)
|
Amodau ar gyfer agor tendrau
|
|
|
|
|
Adran VI: Gwybodaeth Arall
|
VI.1)
|
Nodwch a yw'r broses gaffael hon yn digwydd yn rheolaidd a rhowch Amcangyfrif o pryd y caiff hysbysiadau pellach eu cyhoeddi
|
VI.2)
|
A yw'r contract yn ymwneud â Phrosiect/Rhaglen a ariennir gan Gronfeydd Cymunedol?
Na
|
VI.3)
|
Gwybodaeth Ychwanegol
To express interest and request a copy of the PQQ please email ojeu@ct.catapult.org.uk
The deadline for completed PQQs is 23.6.2014 at 10:00 hours.
Prior to the deadline, Candidates will be able to attend a briefing session on the procurement process.
|
VI.4)
|
Gweithdrefnau ar gyfer apelio
|
VI.4.1)
|
Corff sy'n gyfrifol am y gweithdrefnau apelio
|
|
|
|
|
|
|
|
|
|
|
Corff sy'n gyfrifol am y gweithdrefnau cyfryngu
|
|
|
|
|
|
|
|
|
|
VI.4.2)
|
Cyflwyno apeliadau
|
VI.4.3)
|
Gwasanaeth y gellir cael gwybodaeth ynglŷn â chyflwyno apeliadau oddi wrtho
Cell Therapy Catapult |
|
|
|
|
ojeu@ct.catapult.org.uk |
|
|
|
|
VI.5)
|
Dyddiad yr anfonwyd yr Hysbysiad hwn
20
- 05
- 2014 |
|
ATODIAD B
Gwybodaeth Am Lotiau
|
1
Immune cell therapy manufacture (including gene modified cell therapy) |
1)
|
Disgrifiad Byr
|
2)
|
Geirfa Gaffael Gyffredin (CPV)
|
|
|
|
33600000 |
|
|
|
|
|
3)
|
Maint neu gwmpas
|
4)
|
Syniad o ddyddiadau gwahanol y contract
|
5)
|
Gwybodaeth Ychwanegol am lotiau
|
ATODIAD B
Gwybodaeth Am Lotiau
|
2
Pluripotent derived cell therapy manufacture (iPSC or hESC) |
1)
|
Disgrifiad Byr
|
2)
|
Geirfa Gaffael Gyffredin (CPV)
|
|
|
|
33600000 |
|
|
|
|
|
3)
|
Maint neu gwmpas
|
4)
|
Syniad o ddyddiadau gwahanol y contract
|
5)
|
Gwybodaeth Ychwanegol am lotiau
|
ATODIAD B
Gwybodaeth Am Lotiau
|
3
MSC and other multi-potent cell therapy manufacture |
1)
|
Disgrifiad Byr
|
2)
|
Geirfa Gaffael Gyffredin (CPV)
|
|
|
|
33600000 |
|
|
|
|
|
3)
|
Maint neu gwmpas
|
4)
|
Syniad o ddyddiadau gwahanol y contract
|
5)
|
Gwybodaeth Ychwanegol am lotiau
|
ATODIAD B
Gwybodaeth Am Lotiau
|
4
Other somatic cell therapy manufacture |
1)
|
Disgrifiad Byr
|
2)
|
Geirfa Gaffael Gyffredin (CPV)
|
|
|
|
33600000 |
|
|
|
|
|
3)
|
Maint neu gwmpas
|
4)
|
Syniad o ddyddiadau gwahanol y contract
|
5)
|
Gwybodaeth Ychwanegol am lotiau
|
ATODIAD B
Gwybodaeth Am Lotiau
|
5
3D culture based cell therapy manufacture |
1)
|
Disgrifiad Byr
|
2)
|
Geirfa Gaffael Gyffredin (CPV)
|
|
|
|
33600000 |
|
|
|
|
|
3)
|
Maint neu gwmpas
|
4)
|
Syniad o ddyddiadau gwahanol y contract
|
5)
|
Gwybodaeth Ychwanegol am lotiau
|
|